Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Inventory: 2023-2025

Historic Inventory for Phathom Pharmaceuticals (PHAT) over the last 3 years, with Sep 2025 value amounting to $3.6 million.

  • Phathom Pharmaceuticals' Inventory rose 16.07% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year increase of 16.07%. This contributed to the annual value of $3.2 million for FY2024, which is 165.56% up from last year.
  • Latest data reveals that Phathom Pharmaceuticals reported Inventory of $3.6 million as of Q3 2025, which was up 5.25% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Inventory ranged from a high of $3.6 million in Q3 2025 and a low of $111,000 during Q2 2023.
  • Its 3-year average for Inventory is $2.2 million, with a median of $2.6 million in 2024.
  • Data for Phathom Pharmaceuticals' Inventory shows a peak YoY skyrocketed of 2,702.70% (in 2024) over the last 5 years.
  • Over the past 3 years, Phathom Pharmaceuticals' Inventory (Quarterly) stood at $1.2 million in 2023, then soared by 165.56% to $3.2 million in 2024, then climbed by 16.07% to $3.6 million in 2025.
  • Its Inventory stands at $3.6 million for Q3 2025, versus $3.4 million for Q2 2025 and $3.2 million for Q1 2025.